Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Vincent, Faugeras"'
Publikováno v:
Soft Matter
Soft Matter, Royal Society of Chemistry, 2020, 16 (25), pp.5970-5980. ⟨10.1039/D0SM00667J⟩
Soft Matter, Royal Society of Chemistry, 2020, 16 (25), pp.5970-5980. ⟨10.1039/D0SM00667J⟩
Understanding how small molecules cross cell membranes is crucial to pharmaceutics. Several methods have been developed to evaluate such a process, but they need improvement since many false-positive candidates are often selected. Robust tools enabli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fe4644010363f2216df084ef9276c9d
https://hal.archives-ouvertes.fr/hal-03046328
https://hal.archives-ouvertes.fr/hal-03046328
Publikováno v:
Biophysical Journal. 118:79a
Autor:
Teresa Sementa, Caleb Gakpetor, Nisha Singh, Filippo Basagni, Salvatore Bongarzone, Vincent Faugeras, Antony D. Gee, Jayanta Bordoloi
Publikováno v:
Bongarzone, S, Basagni, F, Sementa, T, Singh, N, Gakpetor, C, Faugeras, V, Bordoloi, J & Gee, A D 2018, ' Development of [ 18 F]FAMTO: A novel fluorine-18 labelled positron emission tomography (PET) radiotracer for imaging CYP11B1 and CYP11B2 enzymes in adrenal glands ', Nuclear Medicine and Biology, vol. 68-69, pp. 14-21 . https://doi.org/10.1016/j.nucmedbio.2018.11.002
IntroductionPrimary aldosteronism accounts for 6–15% of hypertension cases, the single biggest contributor to global morbidity and mortality. Whilst ~50% of these patients have unilateral aldosterone-producing adenomas, only a minority of these hav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::947cb9fdf416d966e81a4e3a0310dd17
https://kclpure.kcl.ac.uk/en/publications/a643b2ad-5267-4869-9fc1-0ade384c7067
https://kclpure.kcl.ac.uk/en/publications/a643b2ad-5267-4869-9fc1-0ade384c7067
Autor:
Salvatore, Bongarzone, Filippo, Basagni, Teresa, Sementa, Nisha, Singh, Caleb, Gakpetor, Vincent, Faugeras, Jayanta, Bordoloi, Antony D, Gee
Publikováno v:
Nuclear Medicine and Biology
Introduction Primary aldosteronism accounts for 6–15% of hypertension cases, the single biggest contributor to global morbidity and mortality. Whilst ~50% of these patients have unilateral aldosterone-producing adenomas, only a minority of these ha